ADC Therapeutics SA (NYSE:ADCT) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 27, 2025 ADC Therapeutics SA beats earnings expectations. Reported EPS is $-0.29, ...